肿瘤预防与治疗2025，Vol.38Issue(2)：107-115,9.DOI:10.3969/j.issn.1674-0904.2025.02.003
2022年全球及中国甲状腺癌发病率和死亡率分析
Incidence and Mortality of Thyroid Cancer Globally and in China in 2022
摘要
Abstract
Objective:To compare the current status of thyroid cancer prevalence in continents and countries with different human development indexes(HDI)in 2022,investi-gate the differences in thyroid cancer incidence and mortality between China and high HDI countries/East Asia,in order to provide a basis for the development of diagnosis strategies for thyroid cancer in China.Methods:Data of thyroid cancer in-cidence and mortality were downloaded and compiled from the GLOBOCAN 2022 database,and the relations of HDI to standardized incidence rate(SIR),standardized mortality rate(SMR),and mortality to incidence ratio(M/I)were analyzed using the Spearman rank correlation coefficient.Results:The ascending order of SIR of thyroid cancer in continents in 2022 were Africa,Europe,Latin America and the Caribbean,Oceania,Asia,and North America,and that of SMR were North America,Europe,Asia,Oceania,Latin America and the Caribbean and Africa.SIR of thyroid cancer(r=0.693,P<0.001)was positively correlated to HDI,while SMR(r=-0.264,P<0.001)and M/I(r=-0.711,P<0.001)were negatively correlated to HDI.The SIR of thyroid cancer in Chi-na was higher than that in East Asia,and the SMR was equal to that in East Asia.SIR of thyroid cancer in China was higher than that in high HDI countries,and SMR was lower than that in high HDI countries.Conclusion:The overdiagnosis of thy-roid cancer is relatively serious in countries with high HDI,such as China.The diagnosis and screening strategies of thyroid cancer should be adjusted in time in China to avoid the waste of medical resources.关键词
甲状腺癌/发病率/死亡率/死亡发病比/人类发展指数Key words
Thyroid cancer/Incidence rate/Mortality rate/Mortality to incidence ratio/Human development index分类
医药卫生引用本文复制引用
葛王舒琦,王中王,胡泽瑞,高敏婵,江澳,张鑫,孔令娜,赵存喜..2022年全球及中国甲状腺癌发病率和死亡率分析[J].肿瘤预防与治疗,2025,38(2):107-115,9.基金项目
This study was supported by grants from Education Department of Anhui Province(No.2024AH040320),Anhui Provincial Key Laboratory of Philosophy and Social Sciences(No.2023-1)and Health Commission of Putuo District,Shanghai(No.2023PTGL07). 安徽省高等学校科学研究重大项目(编号:2024AH040320) （No.2024AH040320）
安徽省哲学社会科学重点实验室开放课题(编号:2023-1) （编号:2023-1）
上海市普陀区卫生健康委员会卫生管理类研究课题(编号:2023PTGL07) （编号:2023PTGL07）
